AFAtinib Regimen (CP-0068) March 2020
|
|
atezolizumab 1200 mg Regimen (CP-0323) May 2023
|
|
atezolizumab 1680 mg Regimen (CP-0330) May 2023
|
|
CARBOplatin AUC 5 gemcitabine 1000 Regimen (CP-0062) May 2020
|
|
CARBOplatin AUC 5 etoposide 100 durvalumab 20 mg/kg Regimen (CP-0215) July 2022
|
|
CARBOplatin AUC 5 etoposide 100 Regimen (CP-0153) January 2021
|
|
CARBOplatin AUC 5 etoposide phosphate 100 Regimen (CP-0415) October 2023
|
|
CARBOplatin AUC 5 gemcitabine 1250 Regimen (CP-0063) March 2020
|
|
CARBOplatin AUC 5 PACLitaxel 175 pembrolizumab 2 mg/kg Regimen (CP-0186) April 2022
|
|
CARBOplatin AUC 5 PEMEtrexed 500 pembrolizumab 2 mg/kg Regimen (CP-0090) May 2020
|
|
CARBOplatin AUC 5 PEMEtrexed 500 Regimen (CP-0064) March 2020
|
|
CISplatin 25 etoposide 100 durvalumab 20 mg/kg Regimen (CP-0216) July 2022
|
|
CISplatin 25 etoposide 100 Regimen (CP-0069) April 2020
|
|
CISplatin 70 gemcitabine 1000 (21 day) Regimen (CP-0065) March 2020
|
|
CISplatin 80 VinORELBine 30 Regimen (CP-0070) April 2020
|
|
crizotinib Regimen (CP-0071) March 2020
|
|
durvalumab 10mg/kg q14d Regimen (CP-0092) June 2021
|
|
durvalumab 20 mg/kg Regimen (CP-0218) July 2022 (Small Cell)
|
|
durvalumab 20mg/kg q28d Regimen (CP-0151) January 2021
|
|
entrectinib 600 mg Regimen (CP-0214) August 2022
|
|
erlotinib Regimen (CP-0072) March 2020
|
|
gefitinib Regimen (CP-0073) January 2020
|
|
lurbinectedin Regimen (CP-0177) February 2022
|
|
nivolumab 3 mg/kg Regimen (CP-0066) March 2020
|
|
nivolumab 360 mg - PACLitaxel 175 - CARBOplatin AUC 5 Regimen (CP-0339) June 2023
|
|
nivolumab 360 pemetrexed 500 CARBOplatin AUC5 Regimen (CP-0343) June 2023
|
|
nivolumab 4.5 mg/kg ipilimumab 1 mg/kg PACLitaxel 175 CARBOplatin AUC5 Regimen Cycle 1 (CP-0336) June 2023
|
|
nivolumab 4.5 mg/kg ipilimumab 1 mg/kg PACLitaxel 175 CARBOplatin AUC5 Regimen Cycles 2+ (CP-0338) June 2023
|
|
nivolumab 4.5 mg/kg ipilimumab 1 mg/kg Regimen (CP-0201) May 2022
|
|
nivolumab 6 mg/kg Regimen (CP-0089) April 2020
|
|
pembrolizumab 2mg/kg Regimen (CP-0067) November 2020
|
|
pembrolizumab 400 mg Regimen (CP-0503) September 2024
|
|
pembrolizumab 4mg/kg q6week Regimen (CP-0152) January 2021
|
|
PEMEtrexed 500 pembrolizumab 2 mgkg Regimen (CP-0091) September 2021
|
|
sotorasib 960 mg Regimen (CP-0364) December 2023
|
|
tepotinib Regimen (CP-0420) January 2024
|
|
topotecan Regimen (CP-0074) January 2020
|
